Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ Pathway

Cell

Volumn 125, Issue 5, 2006, Pages 929-941

  He, Wei ^a   Dorn, David C ^a   Erdjument Bromage, Hediye ^a   Tempst, Paul ^a   Moore, Malcolm A S ^a   Massagué, Joan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STEROID RECEPTOR COACTIVATOR 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; ERYTHROID CELL; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STEM CELL;

MAMMALIA;

EID: 33646876973     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.03.045     Document Type: Article

References (44)

1. Beckstead R., Ortiz J.A., Sanchez C., Prokopenko S.N., Chambon P., Losson R., and Bellen H.J. Bonus, a Drosophila homolog of TIF1 proteins, interacts with nuclear receptors and can inhibit betaFTZ-F1-dependent transcription. Mol. Cell 7 (2001) 753-765
2. Chacko B.M., Qin B.Y., Tiwari A., Shi G., Lam S., Hayward L.J., De Caestecker M., and Lin K. Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Mol. Cell 15 (2004) 813-823
3. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., and Massagué J. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12 (1998) 2144-2152
4. Cohen Y., and Nagler A. Umbilical cord blood transplantation-how, when and for whom?. Blood Rev. 18 (2004) 167-179
5. Davidson A.J., and Zon L.I. Turning mesoderm into blood: the formation of hematopoietic stem cells during embryogenesis. Curr. Top. Dev. Biol. 50 (2000) 45-60
6. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
7. Dupont S., Zacchigna L., Cordenonsi M., Soligo S., Adorno M., Rugge M., and Piccolo S. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121 (2005) 87-99
8. Epperly M.W., Cao S., Goff J., Shields D., Zhou S., Glowacki J., and Greenberger J.S. Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice. Exp. Hematol. 33 (2005) 353-362
9. Feng X.H., and Derynck R. Specificity and selectivity in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21 (2005) 659-666
10. Friedman J.R., Fredericks W.J., Jensen D.E., Speicher D.W., Huang X.P., Neilson E.G., and Rauscher III F.J. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 10 (1996) 2067-2078
11. Hata A., Lo R.S., Wotton D., Lagna G., and Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388 (1997) 82-87
12. Johansson M., Dietrich C., Mandahl N., Hambraeus G., Johansson L., Clausen P.P., Mitelman F., and Heim S. Karyotypic characterization of bronchial large cell carcinomas. Int. J. Cancer 57 (1994) 463-467
13. Khetchoumian K., Teletin M., Mark M., Lerouge T., Cervino M., Oulad-Abdelghani M., Chambon P., and Losson R. TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatids. J. Biol. Chem. 279 (2004) 48329-48341
14. Klugbauer S., and Rabes H.M. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 18 (1999) 4388-4393
15. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., Martin W., Fornwald J., Lehr R., Harling J., et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62 (2002) 58-64
16. Larsson J., and Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene 24 (2005) 5676-5692
17. Le Douarin B., Nielsen A.L., Garnier J.M., Ichinose H., Jeanmougin F., Losson R., and Chambon P. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15 (1996) 6701-6715
18. Massagué J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1 (2000) 169-178
19. Massagué J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
20. Massagué J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
21. Moosmann P., Georgiev O., Le Douarin B., Bourquin J.P., and Schaffner W. Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res. 24 (1996) 4859-4867
22. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
23. Ng K.C., Tan A.M., Chong Y.Y., Lau L.C., and Lou J. Congenital acute megakaryoblastic leukemia (M7) with chromosomal t(1;22)(p13;q13) translocation in a set of identical twins. J. Pediatr. Hematol. Oncol. 21 (1999) 428-430
24. Ohta M., Greenberger J.S., Anklesaria P., Bassols A., and Massagué J. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature 329 (1987) 539-541
25. Peng H., Feldman I., and Rauscher III F.J. Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression. J. Mol. Biol. 320 (2002) 629-644
26. Qin B.Y., Chacko B.M., Lam S.S., de Caestecker M.P., Correia J.J., and Lin K. Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell 8 (2001) 1303-1312
27. Ransom D.G., Bahary N., Niss K., Traver D., Burns C., Trede N.S., Paffett-Lugassy N., Saganic W.J., Lim C.A., Hersey C., et al. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis. PLoS Biol. 2 (2004) E237 10.1371/journal.pbio.0020237
28. Roberts C.W., and Orkin S.H. The SWI/SNF complex-chromatin and cancer. Nat. Rev. Cancer 4 (2004) 133-142
29. Ruscetti F.W., Akel S., and Bartelmez S.H. Autocrine transforming growth factor-beta regulation of hematopoiesis: many outcomes that depend on the context. Oncogene 24 (2005) 5751-5763
30. Sawyer J.R., Thomas E.L., Lukacs J.L., Swanson C.M., Ding Y., Parham D.M., Thomas J.R., and Nicholas R.W. Recurring breakpoints of 1p13 approximately p22 in osteochondroma. Cancer Genet. Cytogenet. 138 (2002) 102-106
31. Schmerer M., and Evans T. Primitive erythropoiesis is regulated by Smad-dependent signaling in postgastrulation mesoderm. Blood 102 (2003) 3196-3205
32. Schultz D.C., Friedman J.R., and Rauscher III F.J. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev. 15 (2001) 428-443
33. Shen M.M., and Schier A.F. The EGF-CFC gene family in vertebrate development. Trends Genet. 16 (2000) 303-309
34. Shi Y., and Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
35. Shizuru J.A., Negrin R.S., and Weissman I.L. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56 (2005) 509-538
36. Sirard C., de la Pompa J.L., Elia A., Itie A., Mirtsos C., Cheung A., Hahn S., Wakeham A., Schwartz L., Kern S.E., et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12 (1998) 107-119
37. Spiegelman B.M., and Heinrich R. Biological control through regulated transcriptional coactivators. Cell 119 (2004) 157-167
38. Sporn M.B., and Roberts A.B. TGF-beta: problems and prospects. Cell Regul. 1 (1990) 875-882
39. Subramanian G., Schwarz R.E., Higgins L., McEnroe G., Chakravarty S., Dugar S., and Reiss M. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Cancer Res. 64 (2004) 5200-5211
40. Underhill C., Qutob M.S., Yee S.P., and Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275 (2000) 40463-40470
41. Venturini L., You J., Stadler M., Galien R., Lallemand V., Koken M.H., Mattei M.G., Ganser A., Chambon P., Losson R., and deThe H. TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. Oncogene 18 (1999) 1209-1217
42. Wisotzkey R.G., Mehra A., Sutherland D.J., Dobens L.L., Liu X., Dohrmann C., Attisano L., and Raftery L.A. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development 125 (1998) 1433-1445
43. Wrana J.L., Attisano L., Wieser R., Ventura F., and Massagué J. Mechanism of activation of the TGF-beta receptor. Nature 370 (1994) 341-347
44. Wu J.W., Hu M., Chai J., Seoane J., Huse M., Li C., Rigotti D.J., Kyin S., Muir T.W., Fairman R., et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol. Cell 8 (2001) 1277-1289